Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV Reactivation in Lymphoma Patients (IHBVRL)
NCT01210287Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Oct 2010
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lamivudine in hepatitis B (HBV), sponsored by Fudan University. Status: unknown.
02
Drugs
lamivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01210287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210287.